Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1/A IPO registration
- 1.1 Form of Underwriting Agreement
- 3.1 Certificate of Incorporation
- 3.2 Certificate of Amendment to the Certificate of Incorporation
- 3.3 Bylaws of Unicycive Therapeutics, Inc
- 5.1 Opinion of Sheppard, Mullin, Richter & Hampton LLP
- 10.1 2018 Equity Incentive Plan
- 10.2 2019 Stock Option Plan
- 10.4 Assignment and Asset Purchase Agreement by and Between the Company and Spectrum Pharmaceuticals, Inc., Dated September 20, 2018
- 10.5 Exclusive License Agreement by and Between the Company and Sphaera Pharma Pte. LTD., Dated October 1, 2017
- 10.6 Service Agreement by and Between the Company and Globavir Biosciences, Inc. Dated July 1, 2017
- 23.1 Consent of Mayer Hoffman Mccann P.C., Independent Registered Public Accounting Firm
- 99.1 Consent of Brigitte Schiller, M.D. to Be Named As a Director Upon Completion of the Offering
Associated filings
- 14 Jul 21 424B4 Prospectus supplement with pricing info
- 13 Jul 21 EFFECT Notice of effectiveness
- 12 Jul 21 S-1/A IPO registration (amended)
- 12 Jul 21 S-1/A IPO registration (amended)
- 30 Jun 21 S-1/A IPO registration (amended)
- 21 Jun 21 S-1/A IPO registration (amended)
-
7 Jun 21 S-1/A IPO registration (amended)
- 21 May 21 S-1 IPO registration
UNCY similar filings
Filing view
External links
